It’s $50M but still light. It is pre-fda approval but still light.
I think MSB just got reminded by the FDA that they are small and not American and the death of American kids by aGvHD doesn’t change that.
Ross from CYP will be ringing Novartis and telling them they have made a big mistake today?
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-119
-
- There are more pages in this discussion • 693 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |